Oct 2026· Journal of the American Medical Association (JAMA)· 0 citations
Medicine
TL;DR
International efforts to determine the prevalence and increase awareness and detection of steatotic liver disease, which affects 1.7 billion people worldwide, including most individuals with obesity or type 2 diabetes, are discussed.
Abstract
This Medical News article discusses international efforts to determine the prevalence and increase awareness and detection of steatotic liver disease, which affects an estimated 1.7 billion people worldwide, including most individuals with obesity or type 2 diabetes.
This JAMA Insights discusses the diagnosis, treatment, and prognosis of metabolic dysfunction–associated steatotic liver disease in children and adolescents.
J. Mann, Christopher D. Byrne, G. Targher· Journal of the American Medi...· 1 citation· ⚡1
HW, et al. Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement. Clin Mol Hepatol 2026;32:289-304
Tatsuki Ichikawa, Satoshi Miuma, Hisamitsu Miyaaki· Hepatobiliary surgery and nu...· 0 citations
Steatotic liver disease (SLD) is an increasingly important cause of hepatocellular carcinoma (HCC), yet validated risk stratification tools remain limited. We aim to evaluate the aMAP score, initially developed for HCC risk prediction mainly in viral hepatitis across international cohorts, in the SLD population.
Wen-Xin Xu, Ya-Ru Shi, Zhi-Hong Liu et al.· Liver international (Print)· 0 citations
